Maersk Raises 2026 Earnings Outlook as Shipping Profits Beat Expectations 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
China Automakers Accelerate Global Expansion as Domestic Car Sales Slump 
ANZ Home Loan Applications Drop 12% After Australia Property Tax Changes 
CBA Posts Record A$10.98B Profit Despite Cautious Outlook 
US Dollar Holds Firm as Fed Outlook and Iran Tensions Keep Markets on Edge 
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast 
Asian Currencies Edge Higher as Soft US Inflation Weighs on Dollar 
Goldman Sachs Eyes Investors for Nvidia’s $500 Billion AI Financing Plan 
KOSPI Eyes Best Weekly Gain Since June as Samsung, SK Hynix Rally 
Ford to Move Some Lincoln Production From China to U.S. in 2030 
Paramount Weighs CNN Sale as $110B Warner Bros. Discovery Deal Faces Antitrust Fight 
Lenovo Revenue Surges 43% as AI Demand Drives Record First-Quarter Growth 
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth 
Oil, Gold Rise as Geopolitical Risks Grip Markets Ahead of U.S. CPI 
Asian Stocks Rally as Cooling US Inflation Boosts Fed Rate Outlook 
Thyssenkrupp Raises 2026 Profit Outlook as Steel and Materials Units Strengthen 
Add as a preferred source on Google
Korea Ginseng Corporation inaugurated its research and development (R&D) center in California. The leading South Korean ginseng producer said on Wednesday, March 15, that it has set up a facility in the United States to expand its presence in the American market while also boosting its sales overseas.
Korea Ginseng Corp. is the maker of the no. 1 ginseng brand in the world known as CheongKwanJang. The opening of its R&D center in the U.S. is a major step toward increasing its market share in the region. Moreover, the center was built so the company can continue developing Korean ginseng into a product that will suit the preference of Americans.
As per The Korea Herald, the ginseng products manufacturer said that with its new R&D center, it would conduct research to find ways of enhancing and broadening the use of its flagship red ginseng products currently being sold in the U.S.
The company especially wants to bolster its products' capability of improving customers' immunity and memory and reducing fatigue. Aside from product development, the center will also serve as a hub that will manage the manufacturing process and quality control of the health products that will be made there.
Korea Ginseng Corp. mentioned its R&D in California will further function as an office for its business ventures in neighboring foreign markets, including Central and South America. The facility will collect data about health drinks and food markets so the company can improve its products based on the information.
"Our US R&D Center will contribute to the construction of local production infrastructure while strengthening the development of customized ginseng products for local consumers," KGC's chief executive officer, Heo Chul Ho, said during the R&D center's inauguration. "The U.S. R&D center will contribute to building infrastructure for a localized manufacturing line as well as strengthening development for localized products."
In a separate press release, the CEO of KGC US, Heung Sil Lee, further said, "This will be a momentous year for our global business. As we meet the unique needs of our U.S. customers by actively developing products specifically tailored to their lifestyles."
